Complete Recovery in Cryptogenic NORSE with Early Immunotherapy: A Case Report
Journal Title: Turkish Journal of Neurology - Year 2021, Vol 27, Issue 1
Abstract
The term new onset refractory status epilepticus (NORSE) is used for patients who do not have a history of seizures and a structural disorder and in whom no etiology can be found. Its treatment is very difficult and its mortality is high. In this article, we present a 62-year-old patient whose etiology was not elucidated despite all examinations and who was diagnosed as having NORSE. Full clinical improvement was achieved with corticosteroid treatment.
Authors and Affiliations
Türkan Acar, Sena Boncuk, Bilgehan Acar, Yeşim Güzey Aras
Causes of Ischemic Stroke in Patients with Atrial Fibrillation
Objective: Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting 1% of the adult population. However, ischemic strokes in patients with AF can be triggered by alternative mechanisms, especially in high...
Thrombolytic Therapy for Stroke in Turkey: Meta-analysis of Published Case Series
Objective: To evaluate the results of published case series originating from Turkey, which may be useful for system planning and institutional goal setting in the clinical practice of intravenous tissue plasminogen activ...
Serum Uric Acid Level, Alzheimer-type Dementia and Variation
No summary
Investigation of Adaptation to Successive Postural Perturbations in Patients with Multiple Sclerosis
Objective: It is well known that abnormal automatic postural responses impair balance control in patients with multiple sclerosis (PwMS) and these responses can be ameliorated with training. However, the difference betwe...
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
no summary